• Refine Query
  • Source
  • Publication year
  • to
  • Language
  • 9
  • 5
  • 1
  • Tagged with
  • 15
  • 14
  • 11
  • 11
  • 11
  • 8
  • 6
  • 6
  • 6
  • 5
  • 5
  • 5
  • 4
  • 4
  • 4
  • About
  • The Global ETD Search service is a free service for researchers to find electronic theses and dissertations. This service is provided by the Networked Digital Library of Theses and Dissertations.
    Our metadata is collected from universities around the world. If you manage a university/consortium/country archive and want to be added, details can be found on the NDLTD website.
11

Cognitive and Neural Mechanisms of Goal-directed Behavior and Their Contribution to Theories of Mental Disorders

Reuter, Benedikt 28 February 2020 (has links)
This is a habilitation thesis submitted to and accepted by the council of the faculty of life sciences at the Humboldt-Universität zu Berlin, Berlin, Germany. The thesis is written in English, but some formal parts (e.g., on the title page) and acknowledgements are written in German language. / Die Research-Domain-Criteria-Initiative und andere haben vorgeschlagen, zur Konzeption psychischer Störungen dimensionale psychologische Konstrukte zu verwenden. Die vorliegende Arbeit beschreibt mehrere Experimente, in denen mit Augenbewegungsaufgaben das Konstrukt der kognitiven Kontrolle evaluiert wurde. Die Studien sollten klären, welche kognitiven und neuronalen Mechanismen zu den bei Menschen mit Schizophrenie oder Zwangsstörung erhöhten Latenzen volitionaler Sakkaden beitragen. In drei Studien wurden Anforderungen der Antisakkadenaufgabe isoliert und funktionelle Magnetresonanztomographie angewendet. Die Ergebnisse legen nahe, dass die verlangsamte volitionale Sakkadengenerierung bei Schizophrenie durch eine dysfunktionale Aktivierung des lateralen präfrontalen Cortex und der supplementären Augenfelder vermittelt wird, was mit Defiziten in der proaktiven Handlungskontrolle verbunden sein könnte. Fünf weitere Experimente sollten Teilprozesse aufklären und haben gezeigt, dass die Defizite möglicherweise aus einer Beeinträchtigung der volitionalen Loslösung der Fixation und der motorischen Vorbereitung resultieren. Zwei weitere Studien legen nahe, dass auch die Zwangsstörung mit erhöhten Latenzen volitionaler Sakkaden assoziiert ist. Effekte experimenteller Variation haben jedoch gezeigt, dass diesen Defiziten wahrscheinlich eine Verlangsamung der Reaktionsauswahl zugrundeliegt. Die bei beiden Patientengruppen vermutlich betroffenen Mechanismen dienen zielgerichteten Verhaltensweisen. Man kann vermuten, dass die Defizite eine Störung auf der Ebene eines allgemeinen Faktors exekutiver Funktionen widerspiegeln. Die experimentellen Ergebnisse weisen jedoch auch auf störungsspezifische Funktionsbeeinträchtigungen hin. Zukünftige Forschung muss den Zusammenhang zwischen diesen Beeinträchtigungen und Symptomen besser aufzuklären, wenn Konzepte psychischer Störungen, die auf experimentell definierten psychologischen Konstrukten basieren, am Ende erfolgreich sein sollen. / The research domain criteria initiative and others have suggested to conzeptualize mental disorders on the basis of dimensional psychological constructs. The present work describes several experiments using eye movement tasks to evaluate the construct of cognitive control. The studies aimed at uncovering cognitive and neural mechanisms involved in increased latencies of volitional saccades as found in individuals with schizophrenia or obsessive-compulsive disorder. Three studies used functional magnetic resonance imaging and isolated different demands of the antisaccade task. The results suggest that slowed volitional saccade generation in schizophrenia is mediated by dysfunctional activation of the lateral prefrontal cortex and the supplementary eye fields, which may relate to deficits in proactive control of action. Five additional behavioral experiments aimed at specifying sub-processes and showed that the deficits might result from impairments in volitional fixation disengagement and motor preparation. Two studies in individuals with obsessive-compulsive disorder suggest that this disorder is also associated with increased latencies of volitional saccades. However, experimental variation revealed that these deficits may reflect a slowing in response selection. The mechanisms affected in both groups are serving goal-directed behaviors and may reflect a disturbance on the level of a common executive functions factor. However, the experimental results also suggest disorder specific functional impairment. Future research will have to improve our understanding of the relationship between these impairments and symptoms if concepts based on experimentally defined psychological constructs shall be successful in the end.
12

Evidence-based guidelines for pharmacological treatment of anxiety disorders

Baldwin, David S., Anderson, Ian M., Nutt, David J., Bandelow, Borwin, Bond, Alyson, Davidson, Jonathan R. T., den Boer, Johan A., Fineberg, Naomi A., Knapp, Martin, Scott, Jan, Wittchen, Hans-Ulrich 30 January 2013 (has links) (PDF)
These British Association for Psychopharmacology guidelines cover the range and aims of treatment for anxiety disorders. They are based explicitly on the available evidence and are presented as recommendations to aid clinical decision making in primary and secondary medical care. They may also serve as a source of information for patients and their carers. The recommendations are presented together with a more detailed review of the available evidence. A consensus meeting involving experts in anxiety disorders reviewed the main subject areas and considered the strength of evidence and its clinical implications. The guidelines were constructed after extensive feedback from participants and interested parties. The strength of supporting evidence for recommendations was rated. The guidelines cover the diagnosis of anxiety disorders and key steps in clinical management, including acute treatment, relapse prevention and approaches for patients who do not respond to first-line treatments.
13

Evidence-based guidelines for pharmacological treatment of anxiety disorders: Recommendations from the British Association for Psychopharmacology

Baldwin, David S., Anderson, Ian M., Nutt, David J., Bandelow, Borwin, Bond, Alyson, Davidson, Jonathan R. T., den Boer, Johan A., Fineberg, Naomi A., Knapp, Martin, Scott, Jan, Wittchen, Hans-Ulrich January 2005 (has links)
These British Association for Psychopharmacology guidelines cover the range and aims of treatment for anxiety disorders. They are based explicitly on the available evidence and are presented as recommendations to aid clinical decision making in primary and secondary medical care. They may also serve as a source of information for patients and their carers. The recommendations are presented together with a more detailed review of the available evidence. A consensus meeting involving experts in anxiety disorders reviewed the main subject areas and considered the strength of evidence and its clinical implications. The guidelines were constructed after extensive feedback from participants and interested parties. The strength of supporting evidence for recommendations was rated. The guidelines cover the diagnosis of anxiety disorders and key steps in clinical management, including acute treatment, relapse prevention and approaches for patients who do not respond to first-line treatments.
14

Overactive Performance Monitoring in Obsessive-Compulsive Disorder: Unraveling Affective Processes and Modulation by Non-Invasive Brain Stimulation

Balzus, Luisa 15 July 2024 (has links)
Eine überaktive Überwachung eigener Handlungen, welche sich in erhöhten Amplituden der error-related negativity (ERN) zeigt, scheint eine zentrale Rolle in der Pathophysiologie der Zwangsstörung zu spielen. Die funktionelle Bedeutsamkeit der ERN, die Mechanismen, die zur erhöhten ERN bei Zwangsstörungen beitragen und der Nutzen der ERN als Ansatzpunkt für Interventionen sind jedoch nicht vollständig geklärt. Diese Dissertation umfasst drei Studien, deren Ziel es war, diese Aspekte zu untersuchen. Studie 1 untersuchte die affektive Bewertung eigener Handlungen und zeigte, dass Handlungen automatisch affektive Valenz zugeschrieben wird. Darauf aufbauend untersuchte Studie 2, ob die ERN die Valenzbewertung von Fehlern widerspiegelt und ob eine veränderte Fehlerbewertung zur erhöhten ERN bei Zwangsstörungen beiträgt. Die Ergebnisse zeigten, dass Personen mit Zwangsstörung eine verminderte Valenzbewertung von Fehlern aufweisen, lieferten aber keine Hinweise auf einen Zusammenhang zwischen ERN und Fehlerbewertung, was nahelegt, dass eine veränderte Fehlerbewertung nicht der erhöhten ERN bei Zwangsstörungen zugrunde liegt. Studie 3 untersuchte, ob die ERN durch nicht-invasive Hirnstimulation modulierbar ist und lieferte Hinweise darauf, dass kathodale transkranielle Gleichstromstimulation über dem prä-supplementär motorischen Areal die ERN bei gesunden Personen und Personen mit Zwangsstörung reduziert. Zusammenfassend zeigen die Studien, dass die Handlungsüberwachung die affektive Bewertung eigener Handlungen umfasst und dass dieser Prozess bei Zwangsstörungen verändert ist; eine veränderte Fehlerbewertung scheint jedoch nicht der erhöhten ERN bei Zwangsstörungen zugrunde zu liegen. Diese Erkenntnisse tragen zum Verständnis neurokognitiver Veränderungen bei dieser Störung bei. Zudem zeigen die Ergebnisse, dass nicht-invasive Hirnstimulation das Potenzial hat, die ERN bei Personen mit Zwangsstörung abzuschwächen. Dies könnte den Weg für neue Interventionsstrategien ebnen. / Overactive performance monitoring, as indicated by increased amplitudes of the error-related negativity (ERN), is considered to play a central role in the pathophysiology of obsessive-compulsive disorder (OCD). However, the functional significance of the ERN, the mechanisms contributing to increased ERN amplitudes in OCD, and the utility of the ERN as a target for intervention are not fully understood. This dissertation comprises three studies that aimed to shed light on these questions. Study 1 examined the affective evaluation of own actions, revealing that affective valence is automatically assigned to actions. Building upon this, Study 2 investigated whether the ERN reflects the valence evaluation of errors and whether altered error evaluation contributes to heightened ERN magnitude in OCD. The results indicated that individuals with OCD show reduced valence evaluation of errors, yet they provided no evidence for an association between ERN and error evaluation, suggesting that altered error evaluation may not underlie elevated ERN magnitude in OCD. Study 3 investigated whether the ERN can be modulated by non-invasive brain stimulation, and provided tentative evidence that cathodal transcranial direct current stimulation over the presupplementary motor area reduces the ERN in healthy individuals and individuals with OCD. In summary, the studies provide evidence that performance monitoring encompasses the affective evaluation of own actions and demonstrate that this process is altered in OCD; however, aberrant error evaluation does not seem to underlie heightened ERN amplitudes in OCD. These insights contribute to the understanding of neurocognitive alterations in this disorder. Additionally, the results suggest that non-invasive brain stimulation has the potential to attenuate the ERN in individuals with OCD, which may pave the way for novel intervention strategies.
15

Evidence-based pharmacological treatment of anxiety disorders, post-traumatic stress disorder and obsessive-compulsive disorder: A revision of the 2005 guidelines from the British Association for Psychopharmacology

Baldwin, David S., Anderson, Ian M., Nutt, David J., Allgulander, Christer, Bandelow, Borwin, den Boer, Johan A., Christmas, David M., Davies, Simon, Fineberg, Naomi, Lidbetter, Nicky, Malizia, Andrea, McCrone, Paul, Nabarro, Daniel, O’Neill, Catherine, Scott, Jan, van der Wee, Nic, Wittchen, Hans-Ulrich 17 September 2019 (has links)
This revision of the 2005 British Association for Psychopharmacology guidelines for the evidence-based pharmacological treatment of anxiety disorders provides an update on key steps in diagnosis and clinical management, including recognition, acute treatment, longer-term treatment, combination treatment, and further approaches for patients who have not responded to first-line interventions. A consensus meeting involving international experts in anxiety disorders reviewed the main subject areas and considered the strength of supporting evidence and its clinical implications. The guidelines are based on available evidence, were constructed after extensive feedback from participants, and are presented as recommendations to aid clinical decision-making in primary, secondary and tertiary medical care. They may also serve as a source of information for patients, their carers, and medicines management and formulary committees.

Page generated in 0.1406 seconds